- Home
- BUSE vs IDYA Comparison
BUSE vs IDYA Comparison
Compare BUSE & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUSE
- IDYA
- Stock Information
- Founded
- BUSE 1868
- IDYA 2015
- Country
- BUSE United States
- IDYA United States
- Employees
- BUSE N/A
- IDYA N/A
- Industry
- BUSE Major Banks
- IDYA Biotechnology: Pharmaceutical Preparations
- Sector
- BUSE Finance
- IDYA Health Care
- Exchange
- BUSE Nasdaq
- IDYA Nasdaq
- Market Cap
- BUSE 2.0B
- IDYA 1.9B
- IPO Year
- BUSE N/A
- IDYA 2019
- Fundamental
- Price
- BUSE $23.28
- IDYA $21.23
- Analyst Decision
- BUSE Buy
- IDYA Strong Buy
- Analyst Count
- BUSE 6
- IDYA 13
- Target Price
- BUSE $27.33
- IDYA $53.42
- AVG Volume (30 Days)
- BUSE 604.1K
- IDYA 1.1M
- Earning Date
- BUSE 07-22-2025
- IDYA 08-05-2025
- Dividend Yield
- BUSE 4.32%
- IDYA N/A
- EPS Growth
- BUSE N/A
- IDYA N/A
- EPS
- BUSE 0.95
- IDYA N/A
- Revenue
- BUSE $430,476,000.00
- IDYA $7,000,000.00
- Revenue This Year
- BUSE $62.99
- IDYA $101.20
- Revenue Next Year
- BUSE $13.08
- IDYA $286.70
- P/E Ratio
- BUSE $24.25
- IDYA N/A
- Revenue Growth
- BUSE 0.48
- IDYA N/A
- 52 Week Low
- BUSE $18.40
- IDYA $13.45
- 52 Week High
- BUSE $28.97
- IDYA $44.42
- Technical
- Relative Strength Index (RSI)
- BUSE 62.44
- IDYA 62.23
- Support Level
- BUSE $22.30
- IDYA $21.08
- Resistance Level
- BUSE $23.52
- IDYA $22.37
- Average True Range (ATR)
- BUSE 0.47
- IDYA 0.92
- MACD
- BUSE 0.05
- IDYA -0.09
- Stochastic Oscillator
- BUSE 92.70
- IDYA 61.72
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech and Wealth Management. The banking segment generates a vast majority of its revenue.
About IDYA IDEAYA Biosciences Inc.
IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.